Barinthus Biotherapeutics Ownership | Who Owns Barinthus Biotherapeutics?


OverviewForecastChart

Barinthus Biotherapeutics Ownership Summary


Barinthus Biotherapeutics is owned by 25.17% institutional investors, and 74.83% retail investors.

VACC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBarinthus Biotherapeutics25.17%-74.83%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202415-9,698,209-0.20%253.96%2-33.33%350.00%
Dec 31, 202315-6.25%9,718,1350.12%253.97%3-25.00%2-33.33%
Sep 30, 2023166.67%9,706,658-1.43%253.83%4-20.00%350.00%
Jun 30, 20231515.38%9,847,143-3.54%253.53%5-2100.00%
Mar 31, 202313-13.33%10,208,776-0.19%263.57%5-1-66.67%

Recent Insider Transactions


DateNameRoleActivityValue
Jun 26, 2023Scheeren Joseph-Buy$24.40K
May 25, 2023Wright Robin-Buy$36.61K
Mar 27, 2023Enright William Chief Executive OfficerSell$36.30K
Aug 25, 2022Griffiths Graham Chief Business OfficerSell$73.87K
Aug 24, 2022Ellis Christopher Chief Operating OfficerSell$176.71K

Insider Transactions Trends


DateBuySell
2024 Q1--
2023 Q22-
2023 Q1-1
2022 Q3-7
2022 Q212

VACC Ownership FAQ


Who Owns Barinthus Biotherapeutics?

Barinthus Biotherapeutics shareholders are primarily institutional investors at 25.17%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Barinthus Biotherapeutics's industry, Biotech Stocks , is 44.97%, which Barinthus Biotherapeutics falls below.

Does Blackrock own Barinthus Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Barinthus Biotherapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools